Fresenius Medical Care is a provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1.89 million individuals worldwide. It has a network of 2,716 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. It offers specialty pharmacy and laboratory services and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Bad Homburg, Frankfurt.

Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare.

Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN.

HeartFlow focuses on precision heart care, combining human ingenuity with technology. HeartFlow’s non-invasive HeartFlow FFRCT Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRCT Analysis is commercially available in the United States, UK, Canada, Europe, and Japan.

B.Braun Avitum AG engages in the development, production, and distribution of medical and pharmaceutical products used in dialysis, plasmapheresis, and other blood treatments. It also operates dialysis stations, and provides medical and consulting services. The company was founded on October 5, 2000 and is headquartered in Melsungen, Germany.

Tasly Pharmaceutical Group Co., Ltd. engages in the development, manufacture and distribution of pharmaceutical products. Its products include herbal medicines, chemical medicines, pharmaceutical substances, herbal extract and tea products, cosmetics and daily hygiene products, and medical equipment. The company was founded on May 10, 1994 and is headquartered in Tianjin, China.

Indena is the world’s leading company in the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries.Indena, a privately owned Italian company, has around 800 employees (10% of them dedicated to full-time research) and has cultivation, manufacturing, and sales in more than 70 countries throughout the world.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Vivacelle Bio is a clinical stage biotechnology company focused on creating products that utilize phospholipid nanoparticle technology. The Company's first product, VBI-1, is a circulatory support fluid that is a colloid non-blood volume expander that appears to be two to three times more effective than the standard treatment for hypovolemia and safer in animal studies/experiments. It's second product, VBI-S, is specifically-designed to elevate blood pressure in septic shock patients. This new class of resuscitation fluids is called VIVACELLE.

MicroPort CRM SRL engages in the production and distribution of medical devices. It specializes in the development of medical technologies for the treatment of cardiovascular diseases. The company is headquartered in Saluggia, Italy.

Alsius develops and distributes a range of intravascular temperature management products to its clients. Alsius’s product portfolio consists of Bone Regeneration, ClariVein, Cranial Stabilisation and Retraction, Decanters, Drill Systems, Epilepsy Treatment, Equipment Drapes, Haemostats, Nero Consumables, Neuro-Monitoring and Drainage, Patient Drapes, ROWENA, and Temperature Management. Alsius was founded in 1991 and is based in California.

Grifols Worldwide Operations Ltd. manufactures and develops pharmaceutical products. The company was founded in 2013 and is headquartered in Dublin, Ireland.

Zoll Circulation, Inc., a subsidiary of Asahi Kasei Corp., is an American company. The firm manufactures cardiac resuscitation devices.

Beijing Chunlizhengda Medical Instruments Co., Ltd. engages in the provision of orthopedic medical devices. Its activities include research and development, manufacture, and sale of implantable orthopedic medical devices, comprising joint and custom prosthesis; and spinal products. The company was founded on February 12, 1998 and is headquartered in Beijing, China.

B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany.

Asahi Kasei Medical Co. Ltd. engages in the development, manufacture and sale of medical devices. It also engages in the development, manufacture and sale of dialyzers, therapeutic apheresis products, leukocyte reduction filters and virus removal filters. The company was founded on July 24, 1974 and is headquartered in Tokyo, Japan.

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.